Not Yet Recruiting
Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT Assessment
NCT07206264
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Fujian Provincial Cancer Hospital Fuzhou, Fujian, China
- Hebei Medical University Tumor Hospital Shijiazhuang, Hebei, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- Shandong Cancer Hospital Jinan, Shandong, China